FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108422002: Dolasetron mesilate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
172956017 Dolasetron mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726181015 Dolasetron mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
172956017 Dolasetron mesylate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
172956017 Dolasetron mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600574011 Dolasetron mesylate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
600574011 Dolasetron mesylate (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
600574011 Dolasetron mesylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726181015 Dolasetron mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
18141000188113 dolasétron mésilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
18141000188113 dolasétron mésilate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron mesylate Is a Product containing dolasetron (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate Is a Dolasetron (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate Has disposition 5-HT3 receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate Is a 5-HT3 receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate Is modification of (attribute) Dolasetron (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesilate 20mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Dolasetron mesylate Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

GB English

US English

Back to Start